GT Medical Jan 2025 a Series of Warren Point Funds LLC (CIK: 0002062221) EDGAR, Information, Filings... CompaniesBIO.Com

GT Medical Jan 2025 a Series of Warren Point Funds LLC

Mailing address
2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703
Phone
(360) 946-0604
State location
Delaware
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

GT Medical Jan 2025 a Series of Warren Point Funds LLC (CIK: 0002062221) is an American company incorporated in the state of Delaware. Head office is located at 2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703. Work in the industry N/A. GT Medical Jan 2025 a Series of Warren Point Funds LLC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by GT Medical Jan 2025 a Series of Warren Point Funds LLC

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002062221-25-000001 (33 Act) Size: KB	Mar-21-2025	021-541720 25758504

Recent 20 filings. View all GT Medical Jan 2025 a Series of Warren Point Funds LLC filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

GT Medical Jan 2025 a Series of Warren Point Funds LLC overview
GT Medical Jan 2025 a Series of Warren Point Funds LLC job
GT Medical Jan 2025 a Series of Warren Point Funds LLC stock
GT Medical Jan 2025 a Series of Warren Point Funds LLC ownership
GT Medical Jan 2025 a Series of Warren Point Funds LLC CEO
GT Medical Jan 2025 a Series of Warren Point Funds LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.